Tumor necrosis factor-α as trigger of platelet activation in patients with heart failure

Pasquale Pignatelli, Luciano De Biase, Luisa Lenti, Giuliano Tocci, Alessandra Brunelli, Roberto Cangemi, Silvia Riondino, Susanna Grego, Massimo Volpe, Francesco Violi

Research output: Contribution to journalArticlepeer-review


The clinical history of patients with heart failure (HF) is complicated by arterial thromboembolism. Platelet activation is reported in this population, but the underlying mechanism has not been clarified. Forty-two patients with HF scored according to New York Heart Association (NYHA) classification had higher levels of collagen-induced platelet aggregation, platelet tumor necrosis factor-α (TNF-α) receptor expression, and serum thromboxane B 2 and higher circulating levels of TNF-α than 20 healthy subjects. Coincubation of platelets from HF patients with an inhibitor of TNF-α receptors significantly reduced collagen-induced platelet aggregation. In vitro study demonstrated that TNF-α amplified the platelet response to collagen; this effect was inhibited by TNF-α receptor antagonist and inhibitors of arachidonic acid metabolism. This study showed that TNF-α behaves as a trigger of platelet activation through stimulation of the arachidonic acid pathway.

Original languageEnglish
Pages (from-to)1992-1994
Number of pages3
Issue number6
Publication statusPublished - Sep 15 2005

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Tumor necrosis factor-α as trigger of platelet activation in patients with heart failure'. Together they form a unique fingerprint.

Cite this